| EVAX Stock | | | USD 1.17 0.02 1.68% |
Evaxion Biotech financial indicator trend analysis is much more than just examining Evaxion Biotech AS latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evaxion Biotech AS is a good investment. Please check the relationship between Evaxion Biotech Total Assets and its Long Term Debt accounts. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
Total Assets vs Long Term Debt
Total Assets vs Long Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Evaxion Biotech AS Total Assets account and
Long Term Debt. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Evaxion Biotech's Total Assets and Long Term Debt is -0.41. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Evaxion Biotech AS, assuming nothing else is changed. The correlation between historical values of Evaxion Biotech's Total Assets and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Evaxion Biotech AS are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Total Assets i.e., Evaxion Biotech's Total Assets and Long Term Debt go up and down completely randomly.
Correlation Coefficient | -0.41 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Total Assets
Total assets refers to the total amount of Evaxion Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Evaxion Biotech AS books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Long Term Debt
Long-term debt is a debt that Evaxion Biotech AS has held for over one year. Long-term debt appears on Evaxion Biotech AS balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Evaxion Biotech AS balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.
Most indicators from Evaxion Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evaxion Biotech AS current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
Issuance Of Capital Stock is likely to rise to about 15.2
M in 2024, whereas
Tax Provision is likely to drop (825.3
K) in 2024.
Evaxion Biotech fundamental ratios Correlations
Click cells to compare fundamentals
Evaxion Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evaxion Biotech fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to
measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to
predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.